165 related articles for article (PubMed ID: 31547144)
1. A Novel Prognostic DNA Methylation Panel for Colorectal Cancer.
Chung HH; Kuo CC; Hsiao CW; Chen CY; Hu JM; Hsu CH; Chou YC; Lin YW; Shih YL
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31547144
[TBL] [Abstract][Full Text] [Related]
2. NKX6.1 hypermethylation predicts the outcome of stage II colorectal cancer patients undergoing chemotherapy.
Chang SY; Kuo CC; Wu CC; Hsiao CW; Hu JM; Hsu CH; Chou YC; Shih YL; Lin YW
Genes Chromosomes Cancer; 2018 May; 57(5):268-277. PubMed ID: 29363224
[TBL] [Abstract][Full Text] [Related]
3. Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancer.
Yan W; Wu K; Herman JG; Xu X; Yang Y; Dai G; Guo M
Clin Epigenetics; 2018; 10():69. PubMed ID: 29796120
[TBL] [Abstract][Full Text] [Related]
4. DNA hypermethylated status and gene expression of
Huang J; Tan ZR; Yu J; Li H; Lv QL; Shao YY; Zhou HH
Onco Targets Ther; 2017; 10():4739-4751. PubMed ID: 29033587
[TBL] [Abstract][Full Text] [Related]
5. WNT5A Promoter Methylation Is Associated with Better Responses and Longer Progression-Free Survival in Colorectal Cancer Patients Treated with 5-Fluorouracil-Based Chemotherapy.
Jiang G; Lin J; Wang W; Sun M; Chen K; Wang F
Genet Test Mol Biomarkers; 2017 Feb; 21(2):74-79. PubMed ID: 28051879
[TBL] [Abstract][Full Text] [Related]
6. Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth.
Wang Y; He T; Herman JG; Linghu E; Yang Y; Fuks F; Zhou F; Song L; Guo M
Clin Epigenetics; 2017; 9():115. PubMed ID: 29075358
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of cancer specific methylation of the CDO1 gene in small bowel cancer.
Kojima K; Nakamura T; Ooizumi Y; Igarashi K; Tanaka T; Yokoi K; Ishii S; Nishizawa N; Katoh H; Kosaka Y; Sato T; Watanabe M; Yamashita K
PLoS One; 2019; 14(1):e0211108. PubMed ID: 30677088
[TBL] [Abstract][Full Text] [Related]
8. SP1 mediates the link between methylation of the tumour suppressor miR-149 and outcome in colorectal cancer.
Wang F; Ma YL; Zhang P; Shen TY; Shi CZ; Yang YZ; Moyer MP; Zhang HZ; Chen HQ; Liang Y; Qin HL
J Pathol; 2013 Jan; 229(1):12-24. PubMed ID: 22821729
[TBL] [Abstract][Full Text] [Related]
9. Clinical Relevance of Plasma DNA Methylation in Colorectal Cancer Patients Identified by Using a Genome-Wide High-Resolution Array.
Lin PC; Lin JK; Lin CH; Lin HH; Yang SH; Jiang JK; Chen WS; Chou CC; Tsai SF; Chang SC
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1419-27. PubMed ID: 25472652
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of spondin-2 predicts poor survival of colorectal carcinoma patients.
Zhang Q; Wang XQ; Wang J; Cui SJ; Lou XM; Yan B; Qiao J; Jiang YH; Zhang LJ; Yang PY; Liu F
Oncotarget; 2015 Jun; 6(17):15095-110. PubMed ID: 25945835
[TBL] [Abstract][Full Text] [Related]
11. Methylation of TMEM176A is an independent prognostic marker and is involved in human colorectal cancer development.
Gao D; Han Y; Yang Y; Herman JG; Linghu E; Zhan Q; Fuks F; Lu ZJ; Guo M
Epigenetics; 2017 Jul; 12(7):575-583. PubMed ID: 28678648
[TBL] [Abstract][Full Text] [Related]
12. High expression of Zinc-finger protein X-linked promotes tumor growth and predicts a poor outcome for stage II/III colorectal cancer patients.
Yan X; Shan Z; Yan L; Zhu Q; Liu L; Xu B; Liu S; Jin Z; Gao Y
Oncotarget; 2016 Apr; 7(15):19680-92. PubMed ID: 26967242
[TBL] [Abstract][Full Text] [Related]
13. Construction of a novel methylation-related prognostic model for colorectal cancer based on microsatellite status.
Cao L; Chen E; Zhang H; Ba Y; Yan B; Li T; Yang J
J Cell Biochem; 2021 Dec; 122(12):1781-1790. PubMed ID: 34397105
[TBL] [Abstract][Full Text] [Related]
14. Quantitative DNA methylation analysis detects cervical intraepithelial neoplasms type 3 and worse.
Lai HC; Lin YW; Huang RL; Chung MT; Wang HC; Liao YP; Su PH; Liu YL; Yu MH
Cancer; 2010 Sep; 116(18):4266-74. PubMed ID: 20564139
[TBL] [Abstract][Full Text] [Related]
15. Prognostic role of methylated free circulating DNA in colorectal cancer.
Philipp AB; Stieber P; Nagel D; Neumann J; Spelsberg F; Jung A; Lamerz R; Herbst A; Kolligs FT
Int J Cancer; 2012 Nov; 131(10):2308-19. PubMed ID: 22362391
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of fibulin-3 gene by promoter methylation in colorectal cancer predicts adverse prognosis.
Tong JD; Jiao NL; Wang YX; Zhang YW; Han F
Neoplasma; 2011; 58(5):441-8. PubMed ID: 21744999
[TBL] [Abstract][Full Text] [Related]
17. An epigenetic marker panel for screening and prognostic prediction of ovarian cancer.
Su HY; Lai HC; Lin YW; Chou YC; Liu CY; Yu MH
Int J Cancer; 2009 Jan; 124(2):387-93. PubMed ID: 18942711
[TBL] [Abstract][Full Text] [Related]
18. CHFR promoter methylation indicates poor prognosis in stage II microsatellite stable colorectal cancer.
Cleven AH; Derks S; Draht MX; Smits KM; Melotte V; Van Neste L; Tournier B; Jooste V; Chapusot C; Weijenberg MP; Herman JG; de Bruïne AP; van Engeland M
Clin Cancer Res; 2014 Jun; 20(12):3261-71. PubMed ID: 24928946
[TBL] [Abstract][Full Text] [Related]
19. SUV39H2 promotes colorectal cancer proliferation and metastasis via tri-methylation of the SLIT1 promoter.
Shuai W; Wu J; Chen S; Liu R; Ye Z; Kuang C; Fu X; Wang G; Li Y; Peng Q; Shi W; Li Y; Zhou Q; Huang W
Cancer Lett; 2018 May; 422():56-69. PubMed ID: 29458143
[TBL] [Abstract][Full Text] [Related]
20. DNA Hypermethylation of SHISA3 in Colorectal Cancer: An Independent Predictor of Poor Prognosis.
Tsai MH; Chen WC; Yu SL; Chen CC; Jao TM; Huang CY; Tzeng ST; Yen SJ; Yang YC
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1481-9. PubMed ID: 25968618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
